Both in Pharmaceuticals
Moleculin Biotech vs Lexaria Bioscience
Over the past year MBRX returned −97.3% and LEXX returned −77.9%; their daily moves had a correlation of -0.16.
MBRX −97.3% LEXX −77.9%Growth of $1, one year, split-adjusted
| Metric | MBRX | LEXX |
|---|---|---|
| Price | $6.50 | $3.08 |
| Market cap | $6.6M | $6.5M |
| Today | +10.36% | +3.01% |
| 1 month | −42.7% | −8.6% |
| 6 months | −87.2% | −78.2% |
| Year to date | −90.2% | −66.7% |
| 1 year | −97.1% | −77.6% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 33.4× |
| Net cash | $7.3M | $3.6M |
| Dividend yield | — | — |
| Volatility (60d) | 869.6% | 836.8% |
| Short % of float | 1.1% | 1.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).